Vaccination against measles, mumps and German measles. I. Medical and epidemiological aspects
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H.
Ugeskrift for Laeger 147(38): 3013-3017
1985
ISSN/ISBN: 0041-5782 PMID: 4071749 Document Number: 252138
Document emailed within 1 workday
Related Documents
Bjerregaard, P.; Pedersen, K.M.; Kamper-Jørgensen, F.; Koch, C.; Pedersen, F.K.; Wagner, A.L.; Zoffmann, H. 1985: Vaccination against measles, mumps and German measles. II. Socio-economic analysis Ugeskrift for Laeger 147(38): 3017-3022Martins, C.; Garly, M-Lill.; Bale, C.; Rodrigues, A.; Benn, C.S.; Whittle, H.; Aaby, P. 2013: Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines Vaccine 31(48): 5766-5771
da Silveira, C.Marcos.; Kmetzsch, C.Iris.; Mohrdieck, R.; Sperb, A.Fagundes.; Prevots, D.Rebecca. 2002: The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, Rio Grande do Sul, Brazil, 1997 International Journal of Epidemiology 31(5): 978-982
Marshall, G.S.; Wright, P.F.; Fenichel, G.M.; Karzon, D.T. 1985: Diffuse retinopathy following measles, mumps, and rubella vaccination Pediatrics 76(6): 989-991
Vetter, R.T.; Johnson, G.M. 1995: Vaccination update. Diphtheria, tetanus, pertussis, mumps, rubella, measles Postgraduate Medicine 98(4): 133-7 141-2 144-5 Passim
Janaszek-Seydlitz, W.ła.; Bucholc, B.; Wysokińska, T.; Górska, P.; Gniadek, G. 2003: Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population Przeglad Epidemiologiczny 57(2): 281-288
Owatanapanich, S.; Wanlapakorn, N.; Tangsiri, R.; Poovorawan, Y. 2014: Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature Southeast Asian Journal of Tropical Medicine and Public Health 45(5): 1053-1057
Trier, H.; Rønne, T. 1992: Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella Ugeskrift for Laeger 154(29): 2008-2013
Gerdes, J.; Thorsen, T. 2006: So dangerous are not measles, mumps and rubella...A qualitative survey of causes of MMR vaccination refusal in the county of Vejle Ugeskrift for Laeger 168(33): 2670-2674
Benn, C.S.; Martins, Cário.L.; Andersen, A.; Fisker, A.B.; Whittle, H.C.; Aaby, P. 2020: Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival Frontiers in Pediatrics 8: 20
Colomer Pache, M.; Arnedo Pena, A. 1988: Study of a measles epidemic in Gátova (Castellón) and the efficacy of measles vaccination Medicina Clinica 91(17): 649-652
Semba, R.D.; Munasir, Z.; Beeler, J.; Akib, A.; Muhilal; Audet, S.; Sommer, A. 1995: Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345(8961): 1330-1332
Balé, C.; Garly, M-Lill.; Martins, C.; Nielsen, J.; Whittle, H.; Aaby, P. 2011: Risk factors for measles in young infants in an urban African area with high measles vaccination coverage Pediatric Infectious Disease Journal 30(8): 689-693
Lowther, S.A.; Curriero, F.C.; Kalish, B.T.; Shields, T.M.; Monze, M.; Moss, W.J. 2009: Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey Lancet 373(9668): 1025-1032
Alberti, K.P.; King, L.A.; Burny, M-Eve.; Ilunga, B.Kebela.; Grais, R.F. 2010: Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005-2006 International health 2(1): 65-68
Zhang, R.Z. 1987: An investigation of the sero-epidemiological effect of emergent vaccination with measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 8(5): 288-290
Heller, T. 2001: Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? how safe is MMR vaccine? Bmj 323(7317): 838-839; Discussion 840
Tikhonova, N.T.; Khrometskaia, T.M.; Livanova, L.V.; Poliakova, T.A.; Azarova, S.A. 1978: Several indices of humoral anti-measles immunity in children, previously immunized with live measles vaccine, who have developed measles Voprosy Virusologii 3: 322-327
Tohme, R.A.; François, J.; Wannemuehler, K.; Magloire, R.; Danovaro-Holliday, M.Carolina.; Flannery, B.; Cavallaro, K.F.; Fitter, D.L.; Purcell, N.; Dismer, A.; Tappero, J.W.; Vertefeuille, J.F.; Hyde, T.B. 2014: Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination Tropical Medicine and International Health: Tm and Ih 19(9): 1105-1115
Babakura, B.; Nomhwange, T.; Jean Baptiste, A.E.; Dede, O.; Taiwo, L.; Abba, S.; Soyemi, M.; Idowu, A.M.; Terna Richard, M.; Braka, F.; Oteri, J.; Shuaib, F. 2021: The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: a case study of 2017/18 measles campaign in Borno state, Nigeria Vaccine 39(Suppl 3): C66-C75